Introduction Imagine a world where life-saving cancer treatments, once out of reach due to exorbitant costs and lengthy production times, become accessible to patients in desperate need through groundbreaking innovations. CAR-T therapy, a revolutionary immunotherapy that modifies a patient's T
I'm thrilled to sit down with Ivan Kairatov, a renowned expert in biopharma with a wealth of experience in research and development, particularly in the rapidly evolving field of cell and gene therapies (CGTs). With his deep knowledge of technology and innovation in the industry, Ivan offers unique
Imagine a biopharmaceutical production line where every process, from drug formulation to final packaging, is mirrored in a virtual environment that predicts failures before they occur, optimizes workflows in real time, and slashes development costs by millions. This isn’t a distant dream but the
The global battle against Helicobacter pylori (H. pylori), a pervasive bacterial infection tied to severe health issues like gastric cancer, is intensifying as public health systems and biopharmaceutical innovators join forces to address this critical challenge. Affecting millions across the world,
In the rapidly advancing realm of biopharmaceutical manufacturing, the pressure to innovate has never been greater, with global demand for life-saving medicines escalating at an unprecedented pace. Bioprocess Digital Twins (BPDTs) have emerged as a groundbreaking technology, offering virtual
Imagine a promising biotech company, poised to revolutionize treatment for a debilitating skin condition, only to see its stock value obliterated overnight by disappointing trial results. This is the reality for Moonlake Immunotherapeutics, a Swiss-based firm that witnessed an 80% plunge in its
